Gilead Aims To Take A Giant Lead In The CAR-T Space – Seeking Alpha
Seeking Alpha |
Gilead Aims To Take A Giant Lead In The CAR–T Space
Seeking Alpha Gilead Sciences creates a collaboration agreement with Pfizer to enhance CAR-T therapy with another immunotherapy drug built to spur T–cell immune response. The future of treatments for CAR-T and other technologies such as RNAi, gene therapy, CRISPR … |
